nodes	percent_of_prediction	percent_of_DWPC	metapath
Leflunomide—PTK2B—embryo—Parkinson's disease	0.0131	0.106	CbGeAlD
Leflunomide—PTK2B—forebrain—Parkinson's disease	0.0116	0.0933	CbGeAlD
Leflunomide—DHODH—head—Parkinson's disease	0.0105	0.0844	CbGeAlD
Leflunomide—PTK2B—cardiovascular system—Parkinson's disease	0.0098	0.0789	CbGeAlD
Leflunomide—DHODH—brain—Parkinson's disease	0.00759	0.0611	CbGeAlD
Leflunomide—AHR—medulla oblongata—Parkinson's disease	0.00689	0.0554	CbGeAlD
Leflunomide—PTK2B—head—Parkinson's disease	0.00664	0.0534	CbGeAlD
Leflunomide—PTK2B—nervous system—Parkinson's disease	0.00629	0.0507	CbGeAlD
Leflunomide—AHR—midbrain—Parkinson's disease	0.00629	0.0507	CbGeAlD
Leflunomide—AHR—spinal cord—Parkinson's disease	0.00614	0.0494	CbGeAlD
Leflunomide—PTK2B—central nervous system—Parkinson's disease	0.00606	0.0488	CbGeAlD
Leflunomide—PTK2B—cerebellum—Parkinson's disease	0.00592	0.0477	CbGeAlD
Leflunomide—AHR—cerebellum—Parkinson's disease	0.00487	0.0392	CbGeAlD
Leflunomide—PTK2B—brain—Parkinson's disease	0.00481	0.0387	CbGeAlD
Leflunomide—AHR—brain—Parkinson's disease	0.00396	0.0318	CbGeAlD
Leflunomide—CYP2C9—cardiovascular system—Parkinson's disease	0.00286	0.023	CbGeAlD
Leflunomide—ABCG2—medulla oblongata—Parkinson's disease	0.00267	0.0215	CbGeAlD
Leflunomide—ABCG2—midbrain—Parkinson's disease	0.00244	0.0197	CbGeAlD
Leflunomide—ABCG2—spinal cord—Parkinson's disease	0.00238	0.0192	CbGeAlD
Leflunomide—PTK2B—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—Parkinson's disease	0.00222	0.00254	CbGpPWpGaD
Leflunomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.0022	0.00252	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—PLA2G6—Parkinson's disease	0.00219	0.0025	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—MAOB—Parkinson's disease	0.00217	0.00248	CbGpPWpGaD
Leflunomide—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00211	0.00241	CbGpPWpGaD
Leflunomide—CYP1A2—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00206	0.00235	CbGpPWpGaD
Leflunomide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00201	0.0023	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL1B—Parkinson's disease	0.002	0.00229	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—TNF—Parkinson's disease	0.00197	0.00225	CbGpPWpGaD
Leflunomide—PTK2B—Interleukin-2 signaling—IL6—Parkinson's disease	0.00197	0.00225	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00195	0.00223	CbGpPWpGaD
Leflunomide—CYP1A2—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00192	0.00219	CbGpPWpGaD
Leflunomide—ABCG2—cerebellum—Parkinson's disease	0.00189	0.0152	CbGeAlD
Leflunomide—PTK2B—TCR Signaling Pathway—MAPK8—Parkinson's disease	0.00184	0.0021	CbGpPWpGaD
Leflunomide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00179	0.00204	CbGpPWpGaD
Leflunomide—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00177	0.00202	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—MAPK8—Parkinson's disease	0.00176	0.00201	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL1B—Parkinson's disease	0.00173	0.00198	CbGpPWpGaD
Leflunomide—CYP1A2—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00173	0.00198	CbGpPWpGaD
Leflunomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00172	0.00196	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.00171	0.00195	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00171	0.00195	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—GSTA4—Parkinson's disease	0.0017	0.00194	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00167	0.0019	CbGpPWpGaD
Leflunomide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00164	0.00187	CbGpPWpGaD
Leflunomide—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00162	0.00184	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CYP2D6—Parkinson's disease	0.00161	0.00184	CbGpPWpGaD
Leflunomide—AHR—Adipogenesis—IL6—Parkinson's disease	0.00159	0.00182	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CTGF—Parkinson's disease	0.00158	0.00181	CbGpPWpGaD
Leflunomide—CYP1A2—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00156	0.00178	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—HGF—Parkinson's disease	0.00154	0.00176	CbGpPWpGaD
Leflunomide—ABCG2—brain—Parkinson's disease	0.00153	0.0123	CbGeAlD
Leflunomide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00153	0.00175	CbGpPWpGaD
Leflunomide—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00151	0.00172	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CYP2E1—Parkinson's disease	0.00148	0.00168	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—NQO1—Parkinson's disease	0.00146	0.00167	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00145	0.00166	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—VPS35—Parkinson's disease	0.00145	0.00166	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—TH—Parkinson's disease	0.00144	0.00164	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00143	0.00163	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00143	0.00163	CbGpPWpGaD
Leflunomide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.0014	0.0016	CbGpPWpGaD
Leflunomide—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00138	0.00158	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—CYCS—Parkinson's disease	0.00138	0.00158	CbGpPWpGaD
Leflunomide—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00137	0.00157	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—CASP3—Parkinson's disease	0.00137	0.00157	CbGpPWpGaD
Leflunomide—PTK2B—Cell-Cell communication—MAPK8—Parkinson's disease	0.00137	0.00156	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00133	0.00152	CbGpPWpGaD
Leflunomide—PTK2B—BDNF signaling pathway—MAPK8—Parkinson's disease	0.00126	0.00144	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00124	0.00142	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—COMT—Parkinson's disease	0.00122	0.0014	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GSTP1—Parkinson's disease	0.00122	0.00139	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—MAOA—Parkinson's disease	0.00121	0.00139	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DGKQ—Parkinson's disease	0.0012	0.00137	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GPR37—Parkinson's disease	0.0012	0.00137	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—HMOX1—Parkinson's disease	0.0012	0.00137	CbGpPWpGaD
Leflunomide—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00117	0.00134	CbGpPWpGaD
Leflunomide—PTK2B—TCR Signaling Pathway—IL6—Parkinson's disease	0.00117	0.00134	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.00116	0.00133	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—ABCB1—Parkinson's disease	0.00115	0.00131	CbGpPWpGaD
Leflunomide—PTK2B—EGF/EGFR Signaling Pathway—MAPK8—Parkinson's disease	0.00115	0.00131	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00115	0.00131	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00113	0.00129	CbGpPWpGaD
Leflunomide—AHR—Circadian rythm related genes—IL6—Parkinson's disease	0.00112	0.00128	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GSTM1—Parkinson's disease	0.00112	0.00128	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PPP1R1B—Parkinson's disease	0.0011	0.00126	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—DCTN1—Parkinson's disease	0.0011	0.00125	CbGpPWpGaD
Leflunomide—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00109	0.00125	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—GPX1—Parkinson's disease	0.00107	0.00122	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.00104	0.00118	CbGpPWpGaD
Leflunomide—PTK2B—VEGFA-VEGFR2 Pathway—IL6—Parkinson's disease	0.00102	0.00117	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by Interleukins—IL6—Parkinson's disease	0.00101	0.00116	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HLA-DRA—Parkinson's disease	0.000997	0.00114	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.000994	0.00114	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—MTHFR—Parkinson's disease	0.000988	0.00113	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PLA2G6—Parkinson's disease	0.000987	0.00113	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00098	0.00112	CbGpPWpGaD
Leflunomide—PTK2B—Signaling by VEGF—IL6—Parkinson's disease	0.000964	0.0011	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—RIT2—Parkinson's disease	0.000961	0.0011	CbGpPWpGaD
Leflunomide—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000933	0.00107	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—APOE—Parkinson's disease	0.00092	0.00105	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GRK5—Parkinson's disease	0.000911	0.00104	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—PARK2—Parkinson's disease	0.0009	0.00103	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—FGF20—Parkinson's disease	0.000893	0.00102	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.000886	0.00101	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.000853	0.000974	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.000849	0.000969	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GRM4—Parkinson's disease	0.000817	0.000933	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL1B—Parkinson's disease	0.000808	0.000923	CbGpPWpGaD
Leflunomide—DHODH—Metabolism—INS—Parkinson's disease	0.000786	0.000897	CbGpPWpGaD
Leflunomide—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.00078	0.000891	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MAG—Parkinson's disease	0.000775	0.000884	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PENK—Parkinson's disease	0.000775	0.000884	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000771	0.00088	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00076	0.000868	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000757	0.000865	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ND3—Parkinson's disease	0.00075	0.000856	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MCCC1—Parkinson's disease	0.00075	0.000856	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—PDYN—Parkinson's disease	0.000708	0.000809	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TALDO1—Parkinson's disease	0.000705	0.000805	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—OMD—Parkinson's disease	0.000705	0.000805	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000705	0.000805	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000697	0.000796	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000695	0.000794	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000688	0.000785	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NDUFB11—Parkinson's disease	0.000668	0.000763	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GFAP—Parkinson's disease	0.000666	0.000761	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—GRM5—Parkinson's disease	0.000659	0.000752	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.000659	0.000752	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ADRBK1—Parkinson's disease	0.000656	0.00075	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000649	0.000742	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000644	0.000736	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GCH1—Parkinson's disease	0.000638	0.000728	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.000602	0.000688	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000594	0.000678	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.000584	0.000667	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	0.000581	0.000664	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	0.00058	0.000662	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FGF20—Parkinson's disease	0.000578	0.000659	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	0.000576	0.000658	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000573	0.000655	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—DBH—Parkinson's disease	0.000568	0.000649	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GBA—Parkinson's disease	0.000568	0.000649	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—FBP1—Parkinson's disease	0.000568	0.000649	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADORA2A—Parkinson's disease	0.00056	0.000639	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000551	0.000629	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—ABL1—Parkinson's disease	0.000535	0.000611	CbGpPWpGaD
Leflunomide—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	0.000534	0.00061	CbGpPWpGaD
Leflunomide—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000527	0.000602	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—INSR—Parkinson's disease	0.000517	0.00059	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—HGF—Parkinson's disease	0.000503	0.000574	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.000499	0.00057	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.000499	0.00057	CbGpPWpGaD
Leflunomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000499	0.00057	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.000497	0.000567	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000497	0.000567	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.000496	0.000566	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.000492	0.000562	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00049	0.000559	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—FGB—Parkinson's disease	0.000488	0.000558	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR1A—Parkinson's disease	0.000486	0.000555	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—TAC1—Parkinson's disease	0.000479	0.000546	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000477	0.000544	CbGpPWpGaD
Leflunomide—PTK2B—Cytokine Signaling in Immune system—IL6—Parkinson's disease	0.000473	0.00054	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DRD1—Parkinson's disease	0.000469	0.000536	CbGpPWpGaD
Leflunomide—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	0.000456	0.000521	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DRD3—Parkinson's disease	0.000455	0.000519	CbGpPWpGaD
Leflunomide—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00045	0.000514	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000424	0.000485	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—DDC—Parkinson's disease	0.000417	0.000476	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000414	0.000473	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR7—Parkinson's disease	0.000411	0.000469	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—DRD2—Parkinson's disease	0.000411	0.000469	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000402	0.000459	CbGpPWpGaD
Leflunomide—ABCG2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000398	0.000454	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTA4—Parkinson's disease	0.000394	0.00045	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.000379	0.000432	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ND3—Parkinson's disease	0.000379	0.000432	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.000356	0.000407	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—OMD—Parkinson's disease	0.000356	0.000407	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—PLA2G6—Parkinson's disease	0.000355	0.000405	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MAOB—Parkinson's disease	0.000351	0.000401	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IGF2—Parkinson's disease	0.000344	0.000393	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000344	0.000392	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.000338	0.000385	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IGF1R—Parkinson's disease	0.000333	0.00038	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—EDN1—Parkinson's disease	0.000329	0.000376	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ND3—Parkinson's disease	0.000324	0.00037	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MCCC1—Parkinson's disease	0.000324	0.00037	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.000322	0.000368	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—OMD—Parkinson's disease	0.000304	0.000347	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TALDO1—Parkinson's disease	0.000304	0.000347	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—NGF—Parkinson's disease	0.000302	0.000345	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.00029	0.000332	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	0.000288	0.000329	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—HTR2A—Parkinson's disease	0.000288	0.000329	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.000287	0.000328	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DBH—Parkinson's disease	0.000287	0.000328	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GBA—Parkinson's disease	0.000287	0.000328	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GCH1—Parkinson's disease	0.000275	0.000314	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—APOE—Parkinson's disease	0.000268	0.000306	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL1B—Parkinson's disease	0.000264	0.000301	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP2D6—Parkinson's disease	0.000261	0.000298	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CTGF—Parkinson's disease	0.000256	0.000292	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000248	0.000283	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GBA—Parkinson's disease	0.000245	0.00028	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—FBP1—Parkinson's disease	0.000245	0.00028	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DBH—Parkinson's disease	0.000245	0.00028	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—MAPK8—Parkinson's disease	0.000242	0.000276	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYP2E1—Parkinson's disease	0.000239	0.000272	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—NQO1—Parkinson's disease	0.000236	0.000269	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—TH—Parkinson's disease	0.000233	0.000266	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—INS—Parkinson's disease	0.000229	0.000261	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—CYCS—Parkinson's disease	0.000223	0.000255	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—DDC—Parkinson's disease	0.000211	0.000241	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTA4—Parkinson's disease	0.000199	0.000227	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—COMT—Parkinson's disease	0.000198	0.000226	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTP1—Parkinson's disease	0.000197	0.000225	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000196	0.000224	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MAOA—Parkinson's disease	0.000196	0.000224	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—HMOX1—Parkinson's disease	0.000194	0.000222	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—ABCB1—Parkinson's disease	0.000186	0.000213	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GSTM1—Parkinson's disease	0.000181	0.000207	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—DDC—Parkinson's disease	0.00018	0.000206	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	0.000179	0.000205	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MAOB—Parkinson's disease	0.000177	0.000202	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—GPX1—Parkinson's disease	0.000173	0.000198	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—CASP3—Parkinson's disease	0.00017	0.000194	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTA4—Parkinson's disease	0.00017	0.000194	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000169	0.000193	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000168	0.000192	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—MTHFR—Parkinson's disease	0.00016	0.000183	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—MAPK8—Parkinson's disease	0.000156	0.000179	CbGpPWpGaD
Leflunomide—PTK2B—Immune System—IL6—Parkinson's disease	0.000155	0.000176	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	0.000153	0.000175	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MAOB—Parkinson's disease	0.000152	0.000173	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—APOE—Parkinson's disease	0.000149	0.00017	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000144	0.000165	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	0.000132	0.00015	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CTGF—Parkinson's disease	0.000129	0.000148	CbGpPWpGaD
Leflunomide—ABCG2—Metabolism—INS—Parkinson's disease	0.000127	0.000145	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	0.000121	0.000138	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—NQO1—Parkinson's disease	0.000119	0.000136	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—TH—Parkinson's disease	0.000117	0.000134	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—CYCS—Parkinson's disease	0.000113	0.000129	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	0.000113	0.000129	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CTGF—Parkinson's disease	0.000111	0.000126	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	0.000103	0.000118	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—NQO1—Parkinson's disease	0.000102	0.000116	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—TH—Parkinson's disease	0.0001	0.000115	CbGpPWpGaD
Leflunomide—PTK2B—Signaling Pathways—IL6—Parkinson's disease	9.99e-05	0.000114	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—COMT—Parkinson's disease	9.99e-05	0.000114	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTP1—Parkinson's disease	9.94e-05	0.000114	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MAOA—Parkinson's disease	9.92e-05	0.000113	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—HMOX1—Parkinson's disease	9.8e-05	0.000112	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—CYCS—Parkinson's disease	9.64e-05	0.00011	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—ABCB1—Parkinson's disease	9.41e-05	0.000107	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GSTM1—Parkinson's disease	9.13e-05	0.000104	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—GPX1—Parkinson's disease	8.75e-05	9.99e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—COMT—Parkinson's disease	8.53e-05	9.75e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTP1—Parkinson's disease	8.49e-05	9.7e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MAOA—Parkinson's disease	8.47e-05	9.68e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—HMOX1—Parkinson's disease	8.38e-05	9.57e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—MTHFR—Parkinson's disease	8.07e-05	9.22e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—ABCB1—Parkinson's disease	8.04e-05	9.18e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GSTM1—Parkinson's disease	7.81e-05	8.91e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—APOE—Parkinson's disease	7.52e-05	8.58e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—GPX1—Parkinson's disease	7.48e-05	8.54e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—MTHFR—Parkinson's disease	6.9e-05	7.88e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—APOE—Parkinson's disease	6.42e-05	7.33e-05	CbGpPWpGaD
Leflunomide—CYP2C9—Metabolism—INS—Parkinson's disease	6.42e-05	7.33e-05	CbGpPWpGaD
Leflunomide—CYP1A2—Metabolism—INS—Parkinson's disease	5.49e-05	6.26e-05	CbGpPWpGaD
